Navigation Links
ACT Receives Positive Opinion for Orphan Drug Designation from European Medicines Agency for hESC-Derived RPE Cells for Treatment of Stargardt's Disease
Date:3/10/2011

MARLBOROUGH, Mass., March 10, 2011 /PRNewswire/ -- Advanced Cell Technology, Inc. (“ACT”; OTC Bulletin Board: ACTC), a leader in the field of regenerative medicine, announced today that the Committee for Orphan Medicinal Products (COMP) of the European Medicines Agency (EMA) has announced a positive opinion of ACT's human embryonic stem cell (hESC)-derived retinal pigment epithelial (RPE) cells for designation as an orphan medicinal product for the treatment of Stargardt's disease. This opinion will now be forwarded by the EMA to the European Commission for their adoption, which should follow in coming weeks.  This follows on the US Food & Drug Administration's granting of Orphan Drug Designation for the same program from ACT, last year.

"We are very pleased to receive this positive opinion for Orphan Drug Designation from the EMA for our hESC-derived RPE cells for the treatment of Stargardt's disease," said Gary Rabin, ACT's interim chairman and CEO. "There is currently no approved treatment for Stargardt's disease, and we are working diligently to move this European trial forward as quickly as possible."

Orphan Drug Designation by the European Commission provides regulatory and financial incentives for companies to develop and market therapies that treat a life-threatening or chronically debilitating condition affecting no more than five in 10,000 persons in the European Union (EU). In addition to a 10-year period of marketing exclusivity in the EU after product approval, Orphan Drug Designation provides companies with scientific advice and regulatory assistance from the EMA during the product development phase, direct access to centralized marketing authorization, as well as reductions in certain fees associated with the application and approval process.

About Stargardt's Disease Stargardt's disease or Stargardt's Macular Dystrophy is
'/>"/>

SOURCE Advanced Cell Technology, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Mylans Matrix Receives FDA Approval Under PEPFAR for Zidovudine Tablets, 100 mg
2. Everist Genomics Laboratory Receives Approval From U.S. Regulatory Authorities For High Complexity Clinical Testing
3. EMD Serono Receives Complete Response Letter From FDA on Cladribine Tablets New Drug Application
4. Rensselaer professor Daniel Lewis receives NSF CAREER Award
5. Pacific Shore Holdings, Inc. Receives Symbol Change Approval From FINRA
6. Boston College receives W.M. Keck Foundation funding for nanoscale optical microscope
7. CMU Receives $1.2 Million NIH Grant To Develop Ethics, Policy Recommendations for Post-Conflict, Post-Disaster DNA ID Practices
8. Dr. Stefan Strauf of physics at Stevens receives NSF CAREER Award for quantum research
9. Onyx Pharmaceuticals Receives Fast Track Designation for Carfilzomib; Company Initiates Rolling NDA Submission for Accelerated Approval
10. Arteriocyte Receives FDA Approval to Move Forward with Critical Limb Ischemia Trial
11. 3SBio Inc. Receives SFDA Approval for TPIAO Label Extension for the Treatment of ITP
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/18/2014)... According to a new market research report ... Global Trends & Forecasts up till 2017”, hydraulic fracturing ... This value is expected to increase from $40 billion ... CAGR during the same period. North America is expected ... terms of hydraulic horse power supplied by the year ...
(Date:10/18/2014)... The “Global Diagnostic Electrocardiograph (ECG) ... End-user (Hospitals, Home/Ambulatory, Research Center, Physician Office, Nursing ... Forecast to 2020” provides a detailed overview of ... trends, and strategies impacting the global diagnostic ECG ... the revenue and share analysis. , The global ...
(Date:10/17/2014)... looking-glass to Wonderland, mirrors in the real world can ... new class of mirror that works like no other. ... (OSA) new high-impact journal Optica , ... type of mirror that forgoes a familiar shiny metallic ... unusual magnetic property of a non-metallic metamaterial. , ...
(Date:10/17/2014)... (PRWEB) October 17, 2014 For ... top employers, as published in today’s print issue ... Careers’ annual Top Employers Survey polled employees in ... the 20 best employers. Rankings were determined ... asked to rate their companies on 23 characteristics, ...
Breaking Biology Technology:Hydraulic Fracturing Market Projected To Reach $64 Billion by 2017 - New Report by MarketsandMarkets 2Hydraulic Fracturing Market Projected To Reach $64 Billion by 2017 - New Report by MarketsandMarkets 3Hydraulic Fracturing Market Projected To Reach $64 Billion by 2017 - New Report by MarketsandMarkets 4The Electrocardiograph (ECG) Market Is Expected to Reach $5,435 Million By 2020 - New Research Report by MarketsandMarkets 2The Electrocardiograph (ECG) Market Is Expected to Reach $5,435 Million By 2020 - New Research Report by MarketsandMarkets 3The Electrocardiograph (ECG) Market Is Expected to Reach $5,435 Million By 2020 - New Research Report by MarketsandMarkets 4The Electrocardiograph (ECG) Market Is Expected to Reach $5,435 Million By 2020 - New Research Report by MarketsandMarkets 5Magnetic mirrors enable new technologies by reflecting light in uncanny ways 2Magnetic mirrors enable new technologies by reflecting light in uncanny ways 3Magnetic mirrors enable new technologies by reflecting light in uncanny ways 4DuPont Named Top Employer by Science Magazine 2DuPont Named Top Employer by Science Magazine 3
... Advanced Cell Technology, Inc. ("ACT"; OTCBB: ACTC), a ... that it has filed a clinical trial application (CTA) ... (MHRA) seeking clearance to initiate its Phase 1/2 clinical ... human embryonic stem cells (hESCs) to treat patients with ...
... Calif., April 20, 2011 Clontech Laboratories, Inc., ... announced the release of the iDimerize inducible ... ARGENT™ technology developed by ARIAD Pharmaceuticals, ... systems enable precise, real-time control of protein-protein interactions ...
... Practice Fusion, the leading EHR and healthcare community ... Paul Willard as Vice President of Marketing and Liz ... of the expanded executive team follows a $23 million ... Health Record system , led by Founders Fund earlier ...
Cached Biology Technology:ACT Files European Clinical Trial Application for Phase 1/2 Study Using Embryonic Stem Cells to Treat Macular Degeneration 2ACT Files European Clinical Trial Application for Phase 1/2 Study Using Embryonic Stem Cells to Treat Macular Degeneration 3ACT Files European Clinical Trial Application for Phase 1/2 Study Using Embryonic Stem Cells to Treat Macular Degeneration 4Announcement - Clontech Laboratories, Inc. Releases the iDimerize™ Cell Signaling and Expression Systems 2Announcement - Clontech Laboratories, Inc. Releases the iDimerize™ Cell Signaling and Expression Systems 3Announcement - Clontech Laboratories, Inc. Releases the iDimerize™ Cell Signaling and Expression Systems 4Practice Fusion Expands Executive Team with New VP of Marketing and Senior Business Development Director 2Practice Fusion Expands Executive Team with New VP of Marketing and Senior Business Development Director 3Practice Fusion Expands Executive Team with New VP of Marketing and Senior Business Development Director 4
(Date:10/16/2014)... wages war on the human body. Battles are ... In pancreatic cancer, this stalemate—known as tumor dormancy—can ... malignant, a phenomena that is poorly understood. ... laboratory of Salvatore Torquato, a Professor of Chemistry ... surrounding tumor dormancy and the switch to a ...
(Date:10/16/2014)... a new synthesis of recent research findings to inform ... the two states. , The Ecology and Management ... A Synthesis of the Relevant Biophysical Science and Implications ... by the U.S. Forest Service,s Pacific Northwest Research Station, ... for a synthesis of the large body of scientific ...
(Date:10/16/2014)... monocultures can be cultivated efficiently, they are anything ... caused by monoculture cultivation is becoming increasingly evident. ... crop form and are regarded as the sole ... – quite wrongfully, finds Bernhard Schmid, an ecology ... a novel form of agriculture and forestry. After ...
Breaking Biology News(10 mins):Modeling tumor dormancy 2New report synthesizes best available science on management of moist mixed-conifer forests 2Plant communities produce greater yield than monocultures 2Plant communities produce greater yield than monocultures 3
... government builds on its $1 billion investment to clean up ... developed innovative new maps of both environmental threats and benefits ... world,s largest fresh water resource. Writing this week (Dec. ... of Science ( PNAS ), a group led by ...
... with pollutants from Asia, transpacific dust plumes deliver vast ... manuscript published online ahead of print in the journal ... detected thousands of unique microbial species, many of which ... David J. Smith, a graduate student at the University ...
... common reed, grows rapidly into dense stands of tall plants ... Early treatment is the key to controlling Phragmites . ... they take over their environment if we don,t know where ... from Michigan Technological University,s Michigan Tech Research Institute (MTRI), the ...
Cached Biology News:Mapping effort charts restoration tack for Great Lakes 2Mapping effort charts restoration tack for Great Lakes 3Dust-plumes power intercontinental microbial migrations 2Following Phragmites home 2
...
D.R. Harper and C. Grose (1994) • Includes: virus structure & replication, fundamental virology, immunology and pathogenesis, vaccines and antiviral drugs, novel diagnostic techniques, cloning a...
IHC Polymer Detection Kit (Rabbit DAB)150 slides...
...
Biology Products: